Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Stempoint Capital LP's stake in Vistagen Therapeutics, Inc. fell to 1.50% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Stempoint Capital LP's stake in Vistagen Therapeutics, Inc. fell to 1.50%, 616,749 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
1.50%
Shares
616,749
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
StemPoint Capital LP1.50%616,749
StemPoint Capital Management GP LLC1.50%616,749
Michelle Ross1.50%616,749

Source

View original at SEC

Related